Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Gabrielli

Showing results (151-160 of 288) with videos related to

Pageof 29
Sort By:
European Heart Journal Supplements : Journal of the European Society of Cardiology|August 30, 2021
ANMCO POSITION PAPER: Prognostic and therapeutic relevance of non-obstructive coronary atherosclerosisGiancarlo Casolo, Domenico Gabrielli, Furio Colivicchi, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 24, 2024
ANMCO/SIMEU consensus document on the use of reversal agents for antithrombotic therapies in patients with ongoing bleeding or at high risk of haemorrhagic eventsLeonardo De Luca, Francesco Rocco Pugliese, Beniamino Susi, et al.
International Journal of Molecular Sciences|June 12, 2026
Heart-Type Fatty Acid-Binding Protein (H-FABP) as a Candidate Adjunctive Biomarker for Immune Checkpoint Inhibitor-Related Cardiotoxicity: Linking Early Immune-Metabolic Myocardial Injury with Translational Cardio-OncologyVincenzo Quagliariello, Massimiliano Berretta, Fabrizio Maurea, et al.
Giornale Italiano Di Cardiologia (2006)|June 17, 2016
[ANMCO/SIT Consensus document: Telemedicine and the emergency/urgency care network]Pasquale Caldarola, Michele Massimo Gulizia, Domenico Gabrielli, et al.
Cardiovascular Drugs and Therapy|January 30, 2024
Hyperkalaemia in Cardiological Patients: New Solutions for an Old ProblemMaurizio Giuseppe Abrignani, Edoardo Gronda, Marco Marini, et al.
JACC. Cardiovascular Imaging|August 19, 2019
Coronary Plaque Features on CTA Can Identify Patients at Increased Risk of Cardiovascular EventsDaniele Andreini, Marco Magnoni, Edoardo Conte, et al.
Giornale Italiano Di Cardiologia (2006)|January 25, 2024
[Lipoprotein(a): relationships with atherosclerosis and valvular heart disease, and emerging therapies]Maurizio Giuseppe Abrignani, Alessandro Maloberti, Stefania Angela Di Fusco, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 22, 2023
ANMCO position paper on the management of hypercholesterolaemia in patients with acute coronary syndromeLeonardo De Luca, Carmine Riccio, Alessandro Navazio, et al.
Giornale Italiano Di Cardiologia (2006)|October 4, 2018
[ANMCO position paper on sacubitril/valsartan in the management of patients with heart failure]Giuseppe Di Tano, Andrea Di Lenarda, Domenico Gabrielli, et al.
Giornale Italiano Di Cardiologia (2006)|July 1, 2023
[ANMCO Position paper: Inclisiran: an innovative therapeutic approach for the clinical management of hypercholesterolemia]Stefania Angela Di Fusco, Pietro Scicchitano, Antonella Spinelli, et al.
Pageof 29

Showing results (151-160 of 288) with videos related to

Sort By:
Pageof 29
European Heart Journal Supplements : Journal of the European Society of Cardiology|August 30, 2021
ANMCO POSITION PAPER: Prognostic and therapeutic relevance of non-obstructive coronary atherosclerosisGiancarlo Casolo, Domenico Gabrielli, Furio Colivicchi, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 24, 2024
ANMCO/SIMEU consensus document on the use of reversal agents for antithrombotic therapies in patients with ongoing bleeding or at high risk of haemorrhagic eventsLeonardo De Luca, Francesco Rocco Pugliese, Beniamino Susi, et al.
International Journal of Molecular Sciences|June 12, 2026
Heart-Type Fatty Acid-Binding Protein (H-FABP) as a Candidate Adjunctive Biomarker for Immune Checkpoint Inhibitor-Related Cardiotoxicity: Linking Early Immune-Metabolic Myocardial Injury with Translational Cardio-OncologyVincenzo Quagliariello, Massimiliano Berretta, Fabrizio Maurea, et al.
Giornale Italiano Di Cardiologia (2006)|June 17, 2016
[ANMCO/SIT Consensus document: Telemedicine and the emergency/urgency care network]Pasquale Caldarola, Michele Massimo Gulizia, Domenico Gabrielli, et al.
Cardiovascular Drugs and Therapy|January 30, 2024
Hyperkalaemia in Cardiological Patients: New Solutions for an Old ProblemMaurizio Giuseppe Abrignani, Edoardo Gronda, Marco Marini, et al.
JACC. Cardiovascular Imaging|August 19, 2019
Coronary Plaque Features on CTA Can Identify Patients at Increased Risk of Cardiovascular EventsDaniele Andreini, Marco Magnoni, Edoardo Conte, et al.
Giornale Italiano Di Cardiologia (2006)|January 25, 2024
[Lipoprotein(a): relationships with atherosclerosis and valvular heart disease, and emerging therapies]Maurizio Giuseppe Abrignani, Alessandro Maloberti, Stefania Angela Di Fusco, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 22, 2023
ANMCO position paper on the management of hypercholesterolaemia in patients with acute coronary syndromeLeonardo De Luca, Carmine Riccio, Alessandro Navazio, et al.
Giornale Italiano Di Cardiologia (2006)|October 4, 2018
[ANMCO position paper on sacubitril/valsartan in the management of patients with heart failure]Giuseppe Di Tano, Andrea Di Lenarda, Domenico Gabrielli, et al.
Giornale Italiano Di Cardiologia (2006)|July 1, 2023
[ANMCO Position paper: Inclisiran: an innovative therapeutic approach for the clinical management of hypercholesterolemia]Stefania Angela Di Fusco, Pietro Scicchitano, Antonella Spinelli, et al.
Pageof 29